Nikolaos Karousis

Dr. Nikolaos Karousis

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2024 in Energy Advances
Verified
Journal Article
Open access
PDF file
NKNikolaos Karousis
Nikolaos Karousis
Dimitrios TasisDimitrios Tasis
Dimitrios Tasis
Porous covalent organic frameworks towards photocatalytic ROS-mediated hydrogen peroxide production and organic substances degradation.

7 July 2025 in Chempluschem
Verified
Journal Article
Open access
ETEirini Tsemperlidou
Eirini Tsemperlidou
NGNikitas Georgiou
Nikitas Georgiou
Demeter TzeliDemeter Tzeli
Demeter Tzeli
NKNikolaos Karousis
Nikolaos Karousis
GVGeorge Varvounis
George Varvounis
A series of new N,N′‐diarylureas is reported as potential cannabinoid‐1 (CB‐1) receptor inhibitors. The synthesis of the new N,N′‐diarylureas is achieved from the reaction of two substituted anilines with the aid of triphosgene. One aniline carries a pyrazol‐1‐yl or 1H‐1,2,3‐triazolyl or 2H‐1,2,3‐triazolyl propan‐2‐one group at position‐3, while the other aniline is substituted by fluoro, bromo, methoxy, cyano, morpholino, or 4‐methyl‐2‐nitro groups. All new compounds are investigated through density functional theory calculations, molecular docking, and molecular dynamics simulations, showing a strong ability to bind to the orthosteric pocket of the CB‐1 receptor and to the allosteric position when CB1 is in complex with agonist AM841. The binding is comparable to that of the well‐known CB‐1 inhibitor PSNBAM‐1. Especially, 1‐{3‐[2‐(1H‐pyrazol‐1‐yl)acetyl]phenyl}‐3‐(4‐methyl‐3‐nitrophenyl)urea presents better theoretical results than PSNBAM‐1.